ATE529408T1 - Verfahren zur herstellung eines vorläufers von montelukast - Google Patents

Verfahren zur herstellung eines vorläufers von montelukast

Info

Publication number
ATE529408T1
ATE529408T1 AT10075051T AT10075051T ATE529408T1 AT E529408 T1 ATE529408 T1 AT E529408T1 AT 10075051 T AT10075051 T AT 10075051T AT 10075051 T AT10075051 T AT 10075051T AT E529408 T1 ATE529408 T1 AT E529408T1
Authority
AT
Austria
Prior art keywords
montelukast
precursor
producing
Prior art date
Application number
AT10075051T
Other languages
English (en)
Inventor
Arjanne Overeem
Reinerus Gerardus Gieling
Jie Zhu
Lambertus Thijs
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Application granted granted Critical
Publication of ATE529408T1 publication Critical patent/ATE529408T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/39—Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT10075051T 2004-04-30 2005-04-14 Verfahren zur herstellung eines vorläufers von montelukast ATE529408T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56660304P 2004-04-30 2004-04-30
US58467504P 2004-07-02 2004-07-02
US11/081,695 US7501517B2 (en) 2004-04-30 2005-03-17 Process for making montelukast and intermediates therefor

Publications (1)

Publication Number Publication Date
ATE529408T1 true ATE529408T1 (de) 2011-11-15

Family

ID=34972158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT10075051T ATE529408T1 (de) 2004-04-30 2005-04-14 Verfahren zur herstellung eines vorläufers von montelukast

Country Status (5)

Country Link
US (1) US7501517B2 (de)
EP (2) EP2181986B1 (de)
AR (1) AR048875A1 (de)
AT (1) ATE529408T1 (de)
WO (1) WO2005105749A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL174758A (en) * 2003-10-10 2012-09-24 Synthon Bv Crystalline form of montelukast, pharmaceutical composition comprising it, process for the preparation thereof and uses thereof as a medicament
US7829716B2 (en) * 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
US7858793B2 (en) * 2004-07-19 2010-12-28 Chava Satyanarayana Methyl 2-[(3S)-[3-[2E)-(7-chloro quinolin-2-yl) ethenyl] phenyl]-3-halopropyl] benzoates
KR100899585B1 (ko) 2005-07-05 2009-05-27 테바 파마슈티컬 인더스트리즈 리미티드 몬테루카스트의 정제
CN101365683A (zh) * 2005-11-18 2009-02-11 斯索恩有限公司 制备孟鲁司特及其中间体的方法
AR057908A1 (es) * 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar montelukast e intermediarios del mismo
WO2007077135A1 (en) 2005-12-30 2007-07-12 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical composition containing montelukast
CN101432267A (zh) * 2006-03-17 2009-05-13 斯索恩有限公司 孟鲁司特金刚烷胺盐
EP1886998A1 (de) 2006-08-09 2008-02-13 Esteve Quimica, S.A. Verfahren zur Reinigung von Montelukast und dessen Aminesalzen
KR20100061571A (ko) 2007-09-28 2010-06-07 코덱시스, 인코포레이티드 케토리덕타제 폴리펩티드 및 이의 용도
CN102046602A (zh) * 2008-04-25 2011-05-04 斯索恩有限公司 制备孟鲁司特中间体的方法
EP2288595B1 (de) 2008-05-26 2016-11-02 Laurus Labs Private Limited Verbessertes verfahren zur herstellung von montelukast und salzen daraus
WO2011121091A1 (en) 2010-03-31 2011-10-06 Krka, D.D., Novo Mesto Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein
HUP1000425A2 (en) 2010-08-11 2012-03-28 Richter Gedeon Nyrt Process for the production of montelukast sodium
US8471030B2 (en) 2010-12-06 2013-06-25 Orochem Technologies Inc. Purification of montelukast using simulated moving bed
CN103467276B (zh) * 2013-09-13 2015-05-06 天津速研医药科技有限公司 一种孟鲁司特钠侧链关键中间体的合成方法
CN111072475A (zh) * 2019-12-20 2020-04-28 牡丹江恒远药业股份有限公司 1-羟甲基环丙基乙酸的合成方法及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565473A (en) * 1990-10-12 1996-10-15 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
US5266568A (en) * 1990-10-12 1993-11-30 Merck Frosst Canada, Inc. Hydroxyalkylquinoline ether acids as leukotriene antagonists
US5856322A (en) * 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
CA2053209C (en) 1990-10-12 1998-12-08 Michel L. Belley Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
TW416948B (en) * 1993-12-28 2001-01-01 Merck & Co Inc Process for the preparation of leukotriene antagonists
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
US5869673A (en) * 1997-02-28 1999-02-09 Merck & Co., Inc. Process for 3-(2-(7-chloro-2-quinolinyl)ethenyl) - benzaldehyde
CN1420113A (zh) * 2001-11-16 2003-05-28 北京上地新世纪生物医药研究所 孟鲁司特钠的制备方法及其制备中间体
CN1171873C (zh) * 2001-12-26 2004-10-20 北京上地新世纪生物医药研究所 一种孟鲁司特钠的制备方法及其制备中间体
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
IL174758A (en) * 2003-10-10 2012-09-24 Synthon Bv Crystalline form of montelukast, pharmaceutical composition comprising it, process for the preparation thereof and uses thereof as a medicament
US7829716B2 (en) * 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor

Also Published As

Publication number Publication date
AR048875A1 (es) 2006-06-07
US7501517B2 (en) 2009-03-10
WO2005105749A3 (en) 2006-03-02
EP2181986A1 (de) 2010-05-05
WO2005105749A2 (en) 2005-11-10
EP2181986B1 (de) 2011-10-19
EP1740546A2 (de) 2007-01-10
US20050245569A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
ATE529408T1 (de) Verfahren zur herstellung eines vorläufers von montelukast
DE502007002646D1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
DE602006004751D1 (de) Verfahren zur Herstellung eines planaren Kondensators
DE602005019848D1 (de) Verfahren zur herstellung von tad- getrocknetem ti
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
ATE479409T1 (de) Verfahren zur herstellung von saugkernen
ATE427997T1 (de) Verfahren zur herstellung von alkylestern
ATE489015T1 (de) Verfahren zur herstellung von verschlüssen
ATE516816T1 (de) Verfahren zur herstellung von impfstoffen
ATE529527T1 (de) Verfahren zur herstellung von alkoholen
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
DE602007001585D1 (de) Verfahren zur herstellung von kunstlatex
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
ATE516362T1 (de) Verfahren zur herstellung von biodiesel
ATE399157T1 (de) Verfahren zur herstellung von telmisartan
ATE540917T1 (de) Verfahren zur herstellung von carbonsäurealkylestern
ATE546436T1 (de) Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
ATE431318T1 (de) Verfahren zur herstellung einer aluminiumart
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
DE502007005615D1 (de) Verfahren zur herstellung eines piezoaktors
ATE554489T1 (de) Verfahren zur herstellung eines transformators
ATE549314T1 (de) Verfahren zur herstellung von 4-aminochinazolinen
ATE542533T1 (de) Verfahren zur herstellung von isothiazol- derivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties